Literature DB >> 26061347

Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response.

Kristine M Erlandson1, Amanda A Allshouse2, Eric Rapaport1, Brent E Palmer1, Cara C Wilson1, Adriana Weinberg1,3,4, Samantha MaWhinney2, Thomas B Campbell1.   

Abstract

Cytomegalovirus (CMV) is associated with poor outcomes, including physical function impairment, in older HIV-uninfected adults. Whether CMV is associated with physical functional impairment in HIV-infected adults is unknown. The primary objective of this study was to determine the relationship between CMV-specific humoral and cell-mediated immune responses with functional impairment in well-controlled HIV infection. In a case-control study, low-function cases were matched by age, gender, and time from HIV diagnosis to high-function controls. Quantitative CMV IgG and %CMV-specific CD8(+) and CD4(+) T cells (interferon-γ expression following CMV pp65 stimulation) were used to estimate physical function. Among 30 low-function cases and 48 high-function matched controls, CMV IgG ranged from <10 to 8,830 EU/ml, including four controls with results <10 EU/ml. Each log10 increase in CMV IgG was associated with 5-fold greater odds of low function (p=0.01); these findings were robust to adjustment for concomitant CD4(+) count, tobacco use, and age; to exclusion of subjects with CMV IgG <10 EU/ml; and to adjustment for hepatitis C viremia. %CMV-specific CD4(+) or CD8(+) T cells were not associated with low function. In bivariable models, the relationship between CMV IgG and physical function was attenuated and was no longer significant when including IL-6, CD4/CD8 ratio, or the Veterans Aging Cohort Study Index score. High levels of CMV-specific IgG were associated with impaired physical function. Attenuation of the strength of this association in bivariable models suggests an indirect relationship mediated by systemic inflammation and immune suppression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26061347      PMCID: PMC4553372          DOI: 10.1089/AID.2015.0085

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  43 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up.

Authors:  Huifen Li; Peter Weng; Kevin Najarro; Qian-Li Xue; Richard D Semba; Joseph B Margolick; Sean X Leng
Journal:  Exp Gerontol       Date:  2014-01-15       Impact factor: 4.032

3.  Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.

Authors:  Giovanni Almanzar; Susanne Schwaiger; Brigitte Jenewein; Michael Keller; Dietmar Herndler-Brandstetter; Reinhard Würzner; Diether Schönitzer; Beatrix Grubeck-Loebenstein
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly.

Authors:  Sine Reker Hadrup; Jan Strindhall; Tania Køllgaard; Tina Seremet; Boo Johansson; Graham Pawelec; Per thor Straten; Anders Wikby
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

5.  Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.

Authors:  George C Wang; Wen Hong L Kao; Peter Murakami; Qian-Li Xue; Roger B Chiou; Barbara Detrick; John F McDyer; Richard D Semba; Vincenzo Casolaro; Jeremy D Walston; Linda P Fried
Journal:  Am J Epidemiol       Date:  2010-04-16       Impact factor: 4.897

6.  Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Lorrie Epling; Juli Teague; Mark A Jacobson; Russell P Tracy; Lawrence Corey; Steven G Deeks
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

7.  Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals.

Authors:  M A McVoy; S P Adler
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

8.  Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response.

Authors:  J Beninga; B Kropff; M Mach
Journal:  J Gen Virol       Date:  1995-01       Impact factor: 3.891

9.  Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy.

Authors:  Kristine M Erlandson; Amanda A Allshouse; Catherine M Jankowski; Syki Duong; Samantha Mawhinney; Wendy M Kohrt; Thomas B Campbell
Journal:  HIV Clin Trials       Date:  2012 Nov-Dec

10.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

View more
  11 in total

Review 1.  The silent war of CMV in aging and HIV infection.

Authors:  Rita B Effros
Journal:  Mech Ageing Dev       Date:  2015-09-25       Impact factor: 5.432

2.  Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.

Authors:  Eshan U Patel; Sara Gianella; Kevin Newell; Aaron A R Tobian; Allison R Kirkpatrick; Fredrick Nalugoda; Mary K Grabowski; Ronald H Gray; David Serwadda; Thomas C Quinn; Andrew D Redd; Steven J Reynolds
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

3.  The Silent Epidemic - Frailty and Aging with HIV.

Authors:  Amanda L Willig; Edgar T Overton; Michael S Saag
Journal:  Total Patient Care HIV HCV       Date:  2016

Review 4.  Inflammation Strikes Again: Frailty and HIV.

Authors:  Stephanie M Fukui; Damani A Piggott; Kristine M Erlandson
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 5.  Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection.

Authors:  Samuel R Schnittman; Peter W Hunt
Journal:  Curr Opin HIV AIDS       Date:  2021-05-01       Impact factor: 4.283

6.  A Unique Gut Microbiome-Physical Function Axis Exists in Older People with HIV: An Exploratory Study.

Authors:  Stephanie M Dillon; Mona H Abdo; Melissa P Wilson; Jay Liu; Catherine M Jankowski; Charles E Robertson; Yunus Tuncil; Bruce Hamaker; Daniel N Frank; Samantha MaWhinney; Cara C Wilson; Kristine M Erlandson
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04-30       Impact factor: 1.723

7.  Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.

Authors:  Maria-Cristina Arcangeletti; Rosita Vasile Simone; Isabella Rodighiero; Flora De Conto; Maria-Cristina Medici; Clara Maccari; Carlo Chezzi; Adriana Calderaro
Journal:  Virol J       Date:  2016-10-22       Impact factor: 4.099

8.  Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery.

Authors:  Elisabet Gómez-Mora; Elisabet García; Victor Urrea; Marta Massanella; Jordi Puig; Eugenia Negredo; Bonaventura Clotet; Julià Blanco; Cecilia Cabrera
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

9.  Cytomegalovirus-specific T-cells are associated with immune senescence, but not with systemic inflammation, in people living with HIV.

Authors:  Vibe Ballegaard; Peter Brændstrup; Karin Kaereby Pedersen; Nikolai Kirkby; Anette Stryhn; Lars P Ryder; Jan Gerstoft; Susanne Dam Nielsen
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

Review 10.  Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.

Authors:  Emily Adland; Paul Klenerman; Philip Goulder; Philippa C Matthews
Journal:  Front Microbiol       Date:  2015-09-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.